FDA
-
-
-
-
-
-
-
Wedbush Downgrades Compass Therapeutics (CMPX) to Neutral
-
-
-
-
-
-
-
Compass Therapeutics Reports 2026 First Quarter Financial Results and Provides Corporate Update
-
-
-
-
-
-
-
William Blair on Compass Therapeutics (CMPX) 75% Drop: 'This will raise questions on the approvability of this dataset'
-
-
-
-
-
-
-
Citizens Starts Compass Therapeutics (CMPX) at Market Outperform
-
-
-
-
-
-
-
Compass Therapeutics Reports 2024 First Quarter Financial Results and Provides Corporate Update
-
-
-
-
-
-
-
Compass Therapeutics Reports Third Quarter 2023 Financial Results and Provides Corporate Update
-
-
-
-
-
-
-
Compass Therapeutics, Inc (CMPX) Reports Q4 Earnings, Provides Corporate Update
-
335,227 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All


